Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of phosphate hemofiltration replacement solution during CRRT
ChiCTR2400080645Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of phosphate in hypophosphatemia (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of hypophosphatemia within 48 hours. Started Feb 2024; status: recruiting.
02
Drugs
phosphate
03
Conditions
hypophosphatemia
Beyond the preview
Go deeper on ChiCTR2400080645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080645.